Samuel Bates Martin - Jan 2, 2024 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
SVP AND CFO
Signature
/s/ Anthony S. Marucci, attorney-in-fact for Samuel Bates Martin
Stock symbol
CLDX
Transactions as of
Jan 2, 2024
Transactions value $
$29,885
Form type
4
Date filed
1/4/2024, 04:05 PM
Previous filing
Jun 20, 2023
Next filing
Jun 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLDX Common Stock Options Exercise $29.9K +10.8K +44.1% $2.78* 35.1K Jan 2, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Incentive Stock Option (Right to Buy) Options Exercise $0 -10.8K -100% $0.00* 0 Jan 2, 2024 Common Stock 10.8K $2.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of June 19, 2023, the option is fully vested.